肝内和肝外胆管癌：流行病学和危险因素的新见解。
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.
机构信息
Vincenzo Cardinale, Rossella Semeraro, Alessia Torrice, Manuela Gatto, Cristina Napoli, Maria Consiglia Bragazzi, Raffaele Gentile, Domenico Alvaro, Dipartimento di Scienze e Biotecnologie Medico-Chirurgiche, Sapienza University of Rome, 00185 Rome, Italy.
出版信息
World J Gastrointest Oncol. 2010 Nov 15;2(11):407-16. doi: 10.4251/wjgo.v2.i11.407.
Abstract
Cholangiocarcinoma (CCA) is a malignant tumour that arises from biliary epithelium at any portion of the biliary tree. CCA is currently classified as intra-hepatic or extra-hepatic CCA (EH-CCA). Recent evidences suggest that intra-hepatic CCA (IH-CCA) and EH-CCA are biologically different cancers, giving further support to a number of recent epidemiological studies showing large differences in terms of incidence, mortality and risk factors. The purpose of this manuscript is to review recent literature dealing with the descriptive epidemiology and risk factors of CCA with a special effort to compare IH- with EH-CCA.
摘要
胆管癌（CCA）是一种起源于胆道树任何部位的胆管上皮的恶性肿瘤。CCA 目前分为肝内或肝外 CCA（EH-CCA）。最近的证据表明，肝内胆管癌（IH-CCA）和 EH-CCA 是生物学上不同的癌症，这进一步支持了一些最近的流行病学研究，这些研究表明在发病率、死亡率和危险因素方面存在很大差异。本文的目的是回顾最近关于 CCA 的描述性流行病学和危险因素的文献，特别努力比较 IH-与 EH-CCA。
相似文献
1
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.肝内和肝外胆管癌：流行病学和危险因素的新见解。
World J Gastrointest Oncol. 2010 Nov 15;2(11):407-16. doi: 10.4251/wjgo.v2.i11.407.
2
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.意大利胆管癌：一项关于临床特征、诊断方式和治疗的全国性调查。结果来自意大利肝病研究协会的“胆管癌”委员会。
Dig Liver Dis. 2011 Jan;43(1):60-5. doi: 10.1016/j.dld.2010.05.002. Epub 2010 Jun 26.
3
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.胆管癌的流行病学、危险因素和发病机制。
HPB (Oxford). 2008;10(2):77-82. doi: 10.1080/13651820801992641.
4
Clinical presentation, risk factors and staging systems of cholangiocarcinoma.胆管癌的临床表现、危险因素及分期系统
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):245-52. doi: 10.1016/j.bpg.2015.02.001. Epub 2015 Feb 14.
5
Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity.胆管癌的多细胞起源是其生物学、流行病学和临床异质性的基础。
World J Gastrointest Oncol. 2012 May 15;4(5):94-102. doi: 10.4251/wjgo.v4.i5.94.
6
Epidemiology of cholangiocarcinoma.胆管癌的流行病学
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):221-32. doi: 10.1016/j.bpg.2015.02.003. Epub 2015 Feb 16.
7
Cholangiocarcinoma: increasing burden of classifications.胆管癌：分类负担日益加重。
Hepatobiliary Surg Nutr. 2013 Oct;2(5):272-80. doi: 10.3978/j.issn.2304-3881.2013.10.02.
8
New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.胆管癌的新见解：多个起源干细胞及相关细胞谱系
Ann Gastroenterol. 2018 Jan-Feb;31(1):42-55. doi: 10.20524/aog.2017.0209. Epub 2017 Nov 2.
9
Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.原发性硬化性胆管炎（PSC）患者的胆管癌：全面综述。
Clin Rev Allergy Immunol. 2020 Feb;58(1):134-149. doi: 10.1007/s12016-019-08764-7.
10
Comparison of the multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma.IgG4相关性硬化性胆管炎与肝外胆管癌的多排螺旋计算机断层扫描结果比较。
Clin Radiol. 2016 Mar;71(3):203-10. doi: 10.1016/j.crad.2015.10.024. Epub 2015 Dec 17.
引用本文的文献
1
LR-M for CT/MRI on LI-RADS v2018: a review of imaging criteria, performance, challenges and future directions from an end-user perspective.基于LI-RADS v2018的CT/MRI肝脏报告和数据系统：从终端用户角度对成像标准、性能、挑战及未来方向的综述
Abdom Radiol (NY). 2025 Aug 14. doi: 10.1007/s00261-025-05132-2.
2
Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.应对炎症性肠病和原发性硬化性胆管炎中的肿瘤风险
Cancers (Basel). 2025 Jun 27;17(13):2165. doi: 10.3390/cancers17132165.
3
Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma.用于评估胆管癌患者免疫治疗的生物标志物
Cancers (Basel). 2025 Feb 6;17(3):555. doi: 10.3390/cancers17030555.
4
WNT signaling contributes to the extrahepatic bile duct proliferative response to obstruction in mice.WNT信号通路有助于小鼠肝外胆管对梗阻的增殖反应。
JCI Insight. 2024 Dec 5;10(2):e181857. doi: 10.1172/jci.insight.181857.
5
Epidemiology of biliary tract cancer in China: A narrative review.中国胆管癌的流行病学：一篇叙述性综述。
Chin J Cancer Res. 2024 Oct 30;36(5):474-488. doi: 10.21147/j.issn.1000-9604.2024.05.02.
6
Prognostic factors in patients with intrahepatic cholangiocarcinoma.肝内胆管细胞癌患者的预后因素。
Sci Rep. 2024 Aug 17;14(1):19084. doi: 10.1038/s41598-024-70124-z.
7
Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study.胆管癌与石棉职业暴露：来自意大利汇总队列研究的新见解。
Med Lav. 2024 Apr 24;115(2):e2024016. doi: 10.23749/mdl.v115i2.14649.
8
Management of Intrahepatic Cholangiocarcinoma: A Narrative Review.肝内胆管癌的管理：一篇叙述性综述。
Cancers (Basel). 2024 Feb 10;16(4):739. doi: 10.3390/cancers16040739.
9
Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies.肝内胆管癌的临床管理：手术方法与全身治疗
Front Oncol. 2024 Jan 24;14:1321683. doi: 10.3389/fonc.2024.1321683. eCollection 2024.
10
Molecular Profile of Intrahepatic Cholangiocarcinoma.肝内胆管癌的分子特征。
Int J Mol Sci. 2023 Dec 29;25(1):461. doi: 10.3390/ijms25010461.
本文引用的文献
1
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.意大利胆管癌：一项关于临床特征、诊断方式和治疗的全国性调查。结果来自意大利肝病研究协会的“胆管癌”委员会。
Dig Liver Dis. 2011 Jan;43(1):60-5. doi: 10.1016/j.dld.2010.05.002. Epub 2010 Jun 26.
2
Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications.不同年龄和性别分层的糖尿病患者发生肝和胆道恶性肿瘤的风险。
Hepatology. 2010 Jul;52(1):155-63. doi: 10.1002/hep.23641.
3
Changes of inflammatory mediators in obese patients after laparoscopic cholecystectomy.腹腔镜胆囊切除术后肥胖患者炎症介质的变化。
World J Surg. 2010 Sep;34(9):2045-50. doi: 10.1007/s00268-010-0616-z.
4
Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.乙型肝炎病毒相关的肝内胆管细胞癌和肝细胞癌可能具有共同的致癌过程。
Eur J Cancer. 2010 Apr;46(6):1056-61. doi: 10.1016/j.ejca.2010.02.005. Epub 2010 Mar 4.
5
Descriptive epidemiology of cholangiocarcinoma in Italy.意大利胆管癌的描述性流行病学。
Dig Liver Dis. 2010 Jul;42(7):490-5. doi: 10.1016/j.dld.2009.10.009. Epub 2009 Dec 22.
6
Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus.肝内胆管癌的危险因素：乙型肝炎病毒的可能作用。
J Viral Hepat. 2010 Oct;17(10):742-8. doi: 10.1111/j.1365-2893.2009.01243.x.
7
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.肝内和肝外胆管癌的危险因素：中国的病例对照研究。
Liver Int. 2010 Feb;30(2):215-21. doi: 10.1111/j.1478-3231.2009.02149.x. Epub 2009 Oct 14.
8
Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003.1978 - 2003年丹麦炎症性肠病患者与非炎症性肠病患者胆管癌的发病率及预后：一项全国队列研究
Eur J Epidemiol. 2009;24(9):513-20. doi: 10.1007/s10654-009-9365-4. Epub 2009 Jun 26.
9
Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma.病毒性肝炎相关的肝内胆管癌与肝细胞癌具有共同的疾病过程。
Br J Cancer. 2009 Jun 2;100(11):1765-70. doi: 10.1038/sj.bjc.6605063. Epub 2009 May 12.
10
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.丙型肝炎病毒感染后发生肝胆胰癌症的风险：一项基于美国退伍军人人群的研究。
Hepatology. 2009 Jan;49(1):116-23. doi: 10.1002/hep.22606.
Zotero 插件